Wang Mei, Ma Jingui, Yang Zhigang, Wang Weibiao, Sa Yuping, Ma Fen, Zhang Weiman, He Xinmin, Chen Guoning, Ma Xueqin
School of Pharmacy, Ningxia Medical University, 1160 Shenli Street, Yinchuan 750001, China.
School of Pharmacy, Ningxia Medical University, 1160 Shenli Street, Yinchuan 750001, China.
Int Immunopharmacol. 2025 Jan 27;146:113837. doi: 10.1016/j.intimp.2024.113837. Epub 2024 Dec 16.
Artemisia annua (A. annua) is a wind-pollinated weed and a major allergen responsible for allergic respiratory diseases in Northern China.
This study involved the separation of pollen proteins from A. annua utilizing SDS-PAGE and Coomassie Blue staining techniques. The effectiveness of extracting allergens from Artemisia annua pollen (AAP) were confirmed both in vivo and in vitro. A mouse model was established using A. annua pollen (AAP) extracts. In vitro, the interaction between allergenic proteins in the AAP extract and specific IgE antibodies present in patients' sera was analyzed, using IgE-immunoblotting and ELISA methods. Protein bands were subsequently analyzed by mass spectrometry. The recombinant Art an 3 (rArt an 3) protein was obtained via recombination, expression, and purification. Finally, the binding activity of rArt an 3 specific IgE was subsequently examined using Western blot and inhibition ELISA (iELISA).
The electrophoretic profiles of AAP showed band patterns ranging from 10 to 70 kDa, with the most prominet IgE-binding pollen proteins detected at approximately 12 kDa. After stimulation of AAP, the sensitized group of mice exhibited significant allergic symptoms compared to the control group. Mass spectrometry analysis identified 7 proteins, including putative aldehyde oxidase Art an 7, Art v 1-like protein, Art an 3.0101 allergen precursor, Art an 3.0102 allergen precursor, Art an 3.0201 allergen precursor, lipid transfer protein 3, and non-specific lipid-transfer protein. The results of immunoblotting and iELISA showed that rArt an 3 could bind to IgE antibodies in the patient sera, and co-incubation of rArt an 3 with serum, the binding serum significantly inhibited IgE binding to the crude AAP.
The Art an 3 is a key allergenic protein in AAP with a high IgE sensitization rate in the studied population sample. These findings enhance our understanding of the sensitization components of AAP and its sensitization characteristics within the Chinese population, thereby promoting the development of precise molecular diagnostics and therapeutic interventions.
黄花蒿是一种风媒授粉杂草,是中国北方过敏性呼吸道疾病的主要过敏原。
本研究采用SDS-PAGE和考马斯亮蓝染色技术从黄花蒿中分离花粉蛋白。在体内和体外均证实了从黄花蒿花粉(AAP)中提取过敏原的有效性。使用黄花蒿花粉(AAP)提取物建立小鼠模型。在体外,采用IgE免疫印迹和ELISA方法分析AAP提取物中的变应原蛋白与患者血清中存在的特异性IgE抗体之间的相互作用。随后通过质谱分析蛋白条带。通过重组、表达和纯化获得重组Art an 3(rArt an 3)蛋白。最后,使用蛋白质印迹法和抑制ELISA(iELISA)检测rArt an 3特异性IgE的结合活性。
AAP的电泳图谱显示条带模式在10至70 kDa之间,在约12 kDa处检测到最突出的IgE结合花粉蛋白。用AAP刺激后,致敏组小鼠与对照组相比表现出明显的过敏症状。质谱分析鉴定出7种蛋白质,包括推定的醛氧化酶Art an 7、Art v 1样蛋白、Art an 3.0101变应原前体、Art an 3.0102变应原前体、Art an 3.0201变应原前体、脂质转移蛋白3和非特异性脂质转移蛋白。免疫印迹和iELISA结果表明,rArt an 3可与患者血清中的IgE抗体结合,rArt an 3与血清共同孵育后,结合血清显著抑制IgE与粗制AAP的结合。
Art an 3是AAP中的关键变应原蛋白,在所研究的人群样本中IgE致敏率较高。这些发现加深了我们对AAP致敏成分及其在中国人群中的致敏特征的理解,从而促进了精确分子诊断和治疗干预措施的发展。